Research Interests - Dr. Tony Lobo
My
students and I have research interests in two areas of microbiology- in
bacterial pathogenesis (the mechanisms by which bacteria cause disease in a
host), and the molecular basis of microbial physiology (the metabolic processes
carried out by microbes for survival and growth).
In both areas, which I describe below in greater detail, I make use of
classical microbiological techniques as well as genetic and molecular approaches
in my investigations.
Escherichia coli is a normal inhabitant of the intestinal tracts of
mammals and birds. Certain strains
of E. coli are capable of causing disease in humans at sites outside the
intestine, such as the urinary tract or the kidney. These strains differ from other E. coli in a few
characteristics that give these strains disease-causing (pathogenic) ability.
One of these traits is the ability to produce a toxin called a hemolysin.
The E. coli hemolysin destroys a variety of host cell types by
creating pores in the outer membrane of the target cells, causing them to burst.
My interests lie in understanding how the structure of the hemolysin
molecule relates to its function in binding to and creating a pore within the
target cell's membrane. For example, the hemolysin requires calcium to be active and
calcium has been shown to bind to the molecule. How does calcium change the structure of the hemolysin to
convert it from an inactive to an active form?
We try to answer this question through a combination of genetic
(engineering mutations into the genes responsible, screening for altered
phenotypes) and biochemical (looking for physical changes in the toxin by column
chromatography, measuring calcium-binding ability of mutant hemolysins)
approaches.
Another bacterial toxin that interests me is another hemolysin, that
produced by Moraxella bovis. M. bovis causes a form of conjunctivitis (pink eye) in
cattle. Not much is known about the
factors that contribute to the pathogenic ability of M. bovis.
I have evidence that the M. bovis hemolysin is related to that of E.
coli. Work awaits to
characterize this toxin further and to determine its role in disease caused by M.
bovis.
My other major research area is study of the molecular biology of a group
of unique microbes called the Archaea (formerly the Archaeobacteria).
These are considered to be an ancient line of organisms, unrelated to any
others on Earth, which today inhabit extreme environments (sulfur-rich anaerobic
sites, hydrothermal vents, hypersaline ponds) that may be remnants of conditions
on the surface of the planet early in its history.
Although the existence of these organisms has been known for quite some
time, relatively little is known about their physiology, biochemistry, and
genetics.
I am investigating two areas of archaeal physiology currently: nitrogen
fixation (the utilization of atmospheric nitrogen gas as a source of cellular
nitrogen) by methane-producing archaea, and transport of substances across
cellular membranes in extremely halophilic archaea. Regarding
the former, as a doctoral student I purified the enzyme responsible for
converting nitrogen gas to ammonia (a form of nitrogen usable by the organism);
I would like to learn more about other proteins involved in nitrogen fixation by
methanogenic archaea, as well as the genes that encode them.
For the latter, we have identified a gene in the extreme halophile Halobacterium
cutirubrum that is homologous to genes encoding membrane-bound transporter
proteins found in organisms ranging from bacteria to humans.
I would like to isolate, or clone, this gene in order to study it further
and find out what role it plays in the physiology of this extreme halophile.
Because homologues of this gene may exist in the three major cell types,
eukaryotic, bacterial, and now possibly archaeal, I am interested in this gene
as an example of one that might have existed in the earliest cellular life forms
on earth. We have also acquired a
phage (a virus of prokaryotic cells) that infects the extreme halophile Halorubrum
coriense. Experiments are
underway aimed at identifying the molecules associated with phage binding.